4171. Livmarli-H-C-PSUSA-00011032-202309 4172. Xtandi-H-C-PSUSA-00010095-202308 4173. Yentreve-H-C-PSUSA-00001187-202308: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 4174. Duloxetine Lilly-H-C-PSUSA-00001187-202308 4175. Cymbalta-H-C-PSUSA-00001187-202308 4176. Nucala-H-C-PSUSA-00010456-202309: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 4177. Kesimpta-H-C-PSUSA-00010927-202309 4178. Voxzogo-H-C-PSUSA-00010952-202308: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 4179. Stribild-H-C-PSUSA-00010082-202308 4180. Aubagio-H-C-PSUSA-00010135-202309 4181. Truvada-H-C-PSUSA-00001210-202304 4182. Deltyba-H-C-PSUSA-00010213-202304: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 4183. Viread-H-C-PSUSA-00002892-202303 4184. Kalydeco-H-C-PSUSA-00009204-202301 4185. Kaftrio-H-C-PSUSA-00010868-202304 4186. Imjudo-H-C-PSUSA/00011038/202304 4187. Mekinist-H-C-PSUSA-00010262-202305 4188. Mektovi-PSUSA-00010717-202306 4189. Tecentriq-H-C-PSUSA-00010644-202305: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 4190. Pravafenix-H-C-PSUSA-00001363-202304 4191. Teriflunomide Mylan-H-C-PSUSA-00010135-202309 4192. Teriflunomide Accord-H-C-PSUSA-00010135-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 4193. Fareston-H-C-PSUSA-00002999-202309 4194. Leflunomide medac-H-C-PSUSA-00001837-202309 4195. Zubsolv-H-C-PSUSA-00002113-202309 4196. Scemblix-H-C-PSUSA-00011008-202310 4197. Buvidal-H-C-PSUSA-00000459-202309 4198. Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s) 4199. Verzenios-H-C-PSUSA-00010724-202309 4200. Jylamvo-H-C-PSUSA-00002014-202310